CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
THRIVE +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03086265
NCT03086265N/ACompleted
CompareCT.gov

The Safety and Efficacy of the Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) for Laser Laryngeal Surgery

Stanford University·interventional·Posted Mar 22, 2017·Updated Mar 17, 2020

In Brief

A clinical study evaluating THRIVE and Endotracheal tube for Otorhinolaryngologic Surgical Procedures and Laser Therapy. Completed, enrolled 20 participants across 1 site.

Detailed Summary

The purpose of this study is to investigate whether laser laryngeal surgery can be safely and potentially more effectively performed without the use of tracheal intubation or jet ventilation, under completely tubeless conditions. The patient's gas exchange will be supported by rapid insufflation of high-flow oxygen through specialized nasal cannula: the so called Transnasal Humidified Rapid- Insufflation Ventilatory Exchange (THRIVE).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOtorhinolaryngologic Surgical Procedures, Laser Therapy
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMar 22, 2017
Enrollment StartMar 24, 2017
Primary CompletionFeb 26, 2019
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 9.3 years ago

Interventions

THRIVEdevice

active nasal oxygen delivery system

Endotracheal tubedevice

Plastic tube for supporting ventilation during surgery